PDS Biotechnology
NASDAQ: PDSBNorth Brunswick, US · Delaware corporation · 2 known investors
NASDAQ-listed company harnessing immunology for therapeutic development
Founders & leadership
FK
Frank K. Bedu-AddoFounder
Investors · 2
Funding
SEC filings, press & company announcements$2M disclosed across 2 of 3 rounds · 2016–2025
- Undisclosed amountregistered direct offeringNov 2025Source ↗
▶$1.1MraisedSep 2016 · 14 investors · BiotechnologyRule 506(b)
▶$1.1MraisedSep 2016 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank K. Bedu-AddoExecutive Officer
- Offering amount
- $10M
- Amount sold
- $1.1M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$902.5KraisedAug 2016 · 12 investors · BiotechnologyRule 506(b)
▶$902.5KraisedAug 2016 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank K. Bedu-AddoExecutive Officer
- Offering amount
- $1M
- Amount sold
- $902.5K
- Minimum investment
- $10K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does PDS Biotechnology do?
- NASDAQ-listed company harnessing immunology for therapeutic development
- Who founded PDS Biotechnology?
- PDS Biotechnology was founded by Frank K. Bedu-Addo.
- Who are PDS Biotechnology's investors?
- PDS Biotechnology's investors include EMV Capital, Yorkville Advisors.
- How much funding has PDS Biotechnology raised?
- PDS Biotechnology has disclosed $2M raised across 2 of its 3 known rounds.
- Where is PDS Biotechnology headquartered?
- PDS Biotechnology is headquartered in North Brunswick, US.